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1. Introduction 
During the course of examining bovine brain lipid 
concentrates for still unidentified hydrocarbons [l-3] 
some trace non-polar fluorescent lipids were observed 
in the concentrates. Our attention was subsequently 
directed towards at least four other recent manuscripts 
[4-71 which have indicated the presence of highly flu; 
orescent trace lipids in brain tissue. Our preliminary 
studies have lead us to suggest hat one of the com- 
pounds, which may be identical to that described by 
Geiger and Bampton [4], has the structure 9-seco- 
cholesta-5 (1 O)-6,8-triene. 
2. Materials and methods 
2.1. Chemicals 
Solvents were distilled in all-glass apparatus, and 
special precautions were taken throughout the oper- 
ations to exclude contaminants, as in previous work 
[2]. The petroleum ether (bg. 30-60°C) was allow- 
ed to stand over concentrated Hz SO4 before distilla- 
tion. Ethyl ether was freshly distilled over LiA1H4. 
Gas-liquid chromatography (GLC) packings on 1 OO/ 
120 mesh Gas Chrom Q were obtained from Applied 
Science Laboratories (State College, Pa.). 
2.2. Thin-layer chromatography (TLC) 
TLC was performed on 20 X 20 cm glass plates 
coated with Silica Gel H, 0.75 mm in thickness applied 
as a water slurry and subsequently activated at 110°C 
North-Holland Publishing Company - Amsterdam 
overnight. Before use the plates were “washed” by as- 
cending chromatography with benzene and ethyl ace- 
tate respectively, then reactivated at 70°C for 1 hr 
before use. Ascending chromatography for purification 
of the fluorescent compound in question was perform- 
ed in two stages: first, using the solvent system I 
(hexane-ethyl ether, 100:5, v/v). In this step the flu- 
orescent band (Rf 0.70) was visualized under long wave 
ultraviolet light (- 280 nm) as a blue fluorescence. This 
band was scraped off the plate, eluted from the silicic 
acid with ethyl acetate, and rechromatographed in the 
same manner in solvent system II (hexane-ethyl ace- 
tate, 100:5, v/v). The fluorescent band (Rf 0.70; lano- 
steryl palmitate standard Rf 0.75) was subsequently 
eluted from the scraped area (visualized under U.V. 
light as above) with ethyl acetate, which was evapo- 
rated at room temp. under Nz for further examination 
of the residue. 
2.3. Physical analytical methods 
Fluorescent spectra were measured on an Aminco- 
Bowman spectrofluorimeter, using 1 mm slit widths 
and a 1 cm square quartz cuvette containing the sam- 
ple in n-heptane. 
Gas-liquid chromatograph (GLC) was accomplished 
with a Varian 1740-l 0 chromatograph, using on-column 
injection onto 1% SE-30 or 3% SE-30 dichlorodimethyl- 
silane-treated columns, 2 m X 2 mm diameter. Carrier 
gas flow was 30 ml/min STP argon. Column tempera- 
ture (200-230°C) was adjusted to give 7-10 min elu- 
tion times for Sa-cholestane with each column. Col- 
umns containing OV-17,OV-210, or OV-225 decom- 
posed the fluorescent compound under examination 
completely in the amounts injected. 
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Mass-spectrometry (MS) was performed on an LKB- 
9000 mass spectrometer, using either direct injection 
or introduction via gas chromatography, with 40 ml/ 
min STP helium flow. Ionizing voltage was 70 eV. 
GLC-MS was accomplished using 1% SE-30 on Gas 
Chrom Q, in a 2 m X 2 mm diameter dichlorodimethyl- 
silane-treated glass column. Column temperature was 
18O”C, and molecular separator temperature was 
25O’C. 
nent (FC-1) which eluted at Rf 0.95 in their alumina 
TLC system in good agreement with their results. In 
our hands this proved to be 98-100% cholesterol as 
assayed by GLC or TLC. Removal of the cholesterol 
by crystallization followed by TLC assay of the fi- 
trates gave the highly fluorescent compound (Rf 0.70 
in system II). 1 
2.4. Isolation and partial purification of one of the 
fluorescent lipids (FC-1) from bovine brain 
When the large quantities of crude benzene fraction 
from Als 0s chromatography are examined at least 3 
other fluorescent compounds can be visualized under 
certain conditions (Ris 0.52,0.23 and 0.17, respec- 
tively). These will be described in a more detailed 
manuscript to be published later. 
Preliminary examination of lipid concentrates of 
small quantities (50-500 g) of rat, rabbit and bovine 
brain indicated that the fluorescent compound de- 
scribed by Geiger and Bampton [4] was present in the 
brains of all three species. Since other minor trace flu- 
orescent lipids were detected in bovine brain (see be- 
low) we will refer to Geiger and Bampton’s compound 
as Fluorescent Compound 1 (FC-1). Since this com- 
pound seemed to be present in all of the brain tissues 
examined in very minute amount, a large quantity (20 
kg) of the more readily available bovine brain tissue 
was processed for isolation and attempted purification 
of FC-1. The brains, freshly obtained from a local 
slaughter house, were freed of blood and meninges, 
homogenized in a Waring Blender in methanol, and 
chloroform was added to make the solvent concentra- 
tion approx. 2: 1 chloroform-methanol. The resulting 
mixture was boiled briefly on a steam bath, filtered 
through glass wool, and freed of solvent by distillation. 
An acetone concentrate of the residue was prepared 
essentially as described by Nicholas et al. [ 11. This 
was subjected to chromatography on alumina as de- 
scribed by Ramsey et al. [2]. Following elution of the 
column with petroleum ether, FC-1 was detected by 
TLC in the first fractions eluted with benzene and 
was purified as indicated under sect. 2.3. 
FC-1 showed a single major peak at a relative reten- 
tion time of 0.95 on 1% SE-30, corresponding to a 
weight concentration of l-2 ng per gram brain wet 
weight. Spectrofluorimetry gave the fluorescence spec- 
trum shown in fig. 1. This spectrum is compatible with 
the structure proposed in fig. 3. Not enough material 
was available for a precise W spectrum, but an absorp- 
tion band between 280-3 10 nm was noted. This ab- 
sorption, and the activation peak of the fluorescence 
spectrum, are both similar to the W absorption spec- 
tra of known conjugated steroid trienols [8]. FC-1 is 
nonsaponifiable, and LiALH4 reduction failed to chan- 
ge its chromatographic or fluorescent properties. The 
fluorescence is destroyed by Hz -Pt reduction at room 
temp. @I, : 40 psi). 
3. Results 
3.1. Purification and properties of FC-1 200 
Repetition of Geiger and Bampton’s procedure [4] 
using 50 g rabbit brain gave a fluorescent fraction 
weighing 30 mg and containing a fluorescent compo- 
Fig. 1. Fluorescence spectrum of FC-1. A) Activation spec- 
trum for 360 nm emission. B) Emission spectrum for 295 mn 
activation. 
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3.2. Mass spectrometry (MS) 
Direct probe MS of the TLC purified FC-1 gave the 
spectrum shown in fig. 2. GLC-MS gave a spectrum 
consisting mostly of column background, especially 
at lower m/e (mass/charge) values. Only 5 peaks did 
not correspond to background peaks: m/e 213,247, 
260,353, and 368. The fact that these are identical 
to the only major peaks in the direct probe spectrum 
which would not be expected to be obscured by col- 
umn background, supports the conclusion that the 
GLC peak represents the same compound seen in the 
direct probe spectrum. 
The major peaks in fig. 2 were interpreted to have 
resulted from the fragmentations shown in fig. 3. 
Metastable peaks support the fragmentation of m/e 
368 into m/e 353,260 and 247; and m/e 353 into 
m/e 255 and 213. 
3.3. Structure 
We propose the structure of FC-1 to be 9-seco- 
cholesta-5( 10),6,8-triene (fig. 3;. Our conclusions 
are based on the following evidence: 
1) It is nonpolar on TLC and column chromatography, 
having the mobility expected of a steroid hydro- 
carbon. 
2) It is resistant to LiALH4 reduction (and saponifica- 
tion), signifying lack of any carboxyl oxygen. 
3) It is readily reduced by Hz -Pt, the fluorescence dis- 
appearing on such reduction. 
4) Its retention time on GLC suggests a molecular 
weight of 300-400. 
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Fig. 3. Proposed structure of FC-1 with major fragmentation 
noted. 
5) The fluorescence spectral data are consistent with 
the suggested structure. 
6) A molecule of the proposed structure would be ex- 
pected to undergo fragmentations like those observ- 
ed in the direct probe mass spectrum. 
Not enough is known about the fragmentation of 
this type of compound to rule out positional isomers 
of the proposed double bond system. 
4. Discussion 
It seems possible that one of the causes of discrep- 
ancies in the literature on trace fluorescent components 
of brain may be due to the extremely low concentra- 
tions of the fluorescent components and the difficulty 
Fig. 2. Direct probe mass spectrum of FC-1. 
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in separation from the large amounts of other lipids, 
principally cholesterol. 
It would be premature at this time to speculate on 
the origin of FC-1. Lunt and Rowe {S] and Khan and 
Hess [7] have suggested that some of the highly fluo- 
rescent trace lipids in brain may have a sterol structure. 
However, the compounds they studied are consider- 
ably more polar than FC-1, and no direct comparison 
with our work can therefore be made. The fluorescence 
spectra published by Khan and Hess [7] indicate that 
the chromophoric groups responsible for fluorescence 
in the components they studied are not the same as 
those of FC-1. Some preliminary synthetic prepara- 
tions involving removal of the hydroxyl group from 
cholecalciferol have tended to verify our suggested 
structure for FC-1. At the moment FC-1 appears 
closely related to cholecalciferol and 7-dehydrochol- 
esterol, and may be a metabolite thereof. Other tis- 
sues must be examined for the presence of the com- 
pound to assist in establishing its origin, since it may 
not be unique to brain tissue. 
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